Analysis of Cardiovascular Disease in Chinese Inpatients with Chronic Kidney Disease

被引:14
作者
Chen, Xiao-Nong [1 ]
Pan, Xiao-Xia [1 ]
Yu, Hai-Jin [1 ]
Shen, Ping-Yan [1 ]
Zhang, Qian-Ying [1 ]
Zhang, Wen [1 ]
Ren, Hong [1 ]
Qian, Ying [1 ]
Zhu, Ping [1 ]
Chen, Nan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China
关键词
chronic kidney disease; cardiovascular disease; prevalence; RENAL-DISEASE; RISK; CKD; PREVALENCE; FAILURE; EVENTS;
D O I
10.2169/internalmedicine.50.5158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the prevalence of cardiovascular disease (CVD) in a Chinese patient population with different stages of chronic kidney disease (CKD). Methods Six hundred and two CKD patients who were hospitalized in Ruijin Hospital between Jan. 2004 and Jan. 2006 were selected. Patients' medical histories and the results of laboratory tests were reviewed. Results The prevalence of CVD in 602 patients with CKD stages 1 to 5 was 1.28%, 17.24%, 22.86%, 33.33%, 56.2% respectively. The prevalence of CVD in CKD stage 5 patients with dialysis was 78.51%. In all the patients, the prevalence of coronary artery disease (CAD), left ventricular hypertrophy (LVH), and congestive heart failure (CHF) was 8.64% (52/602), 26% (154/602), and 13% (78/602), respectively. Regarding co-morbidities of CVD, 34.52% of patients had 2 or more of the above abnormalities. The prevalence of CAD in patients with CKD stages 1 to 5 respectively was 1.28%, 5.75%, 7.86%, 10.26%, 12.33%; LVH was 0%, 11.49%, 16.43%, 29.49%, 44.75%; and CHF was 0%, 3.45%, 3.57%, 8.97%, 28.77%. Conclusion The occurrence of CVD started from CKD stage 1 and increased with the progression of CKD. The screening and prevention of CVD should begin at CKD stage 1.
引用
收藏
页码:1797 / 1801
页数:5
相关论文
共 23 条
[1]   Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP) [J].
Brown, WW ;
Peters, RM ;
Ohmit, SE ;
Keane, WF ;
Collins, A ;
Chen, SC ;
King, K ;
Klag, MJ ;
Molony, DA ;
Flack, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :22-35
[2]   Identifying critically ill patients at high risk for developing acute renal failure: A pilot study [J].
Chawla, LS ;
Abell, L ;
Mazhari, R ;
Egan, M ;
Kadambi, N ;
Burke, HB ;
Junker, C ;
Seneff, MG ;
Kimmel, PL .
KIDNEY INTERNATIONAL, 2005, 68 (05) :2274-2280
[3]   Community-based study on CKD subjects and the associated risk factors [J].
Chen, Nan ;
Wang, Weiming ;
Huang, Yanping ;
Shen, Pingyan ;
Pei, Daoling ;
Yu, Haijin ;
Shi, Hao ;
Zhang, Qianying ;
Xu, Jing ;
Lv, Yilun ;
Fan, Qishi .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) :2117-2123
[4]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[5]   Long-term evolution of cardiomyopathy in dialysis patients [J].
Foley, RN ;
Parfrey, PS ;
Kent, GM ;
Harnett, JD ;
Murray, DC ;
Barre, PE .
KIDNEY INTERNATIONAL, 1998, 54 (05) :1720-1725
[6]   CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY [J].
FOLEY, RN ;
PARFREY, PS ;
HARNETT, JD ;
KENT, GM ;
MARTIN, CJ ;
MURRAY, DC ;
BARRE, PE .
KIDNEY INTERNATIONAL, 1995, 47 (01) :186-192
[7]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[8]  
HOU FF, 2005, NATL MED J CHINA, V7, P458
[9]   The management of CKD: A look into the future [J].
Khwaja, A. ;
El Kossi, M. ;
Floege, J. ;
El Nahas, M. .
KIDNEY INTERNATIONAL, 2007, 72 (11) :1316-1323
[10]  
KUCHERER HF, 1992, J CARDIOVASC PHARM, V19, pS81